CalciMedica, Inc. (CALC)
USD 2.74
(-1.44%)
USD 2.74
(-1.44%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -25.73 Million | -22.87 Million | -31.5 Million | -32.06 Million | -31.21 Million | -28.21 Million |
| Net Income | -34.35 Million | -35.6 Million | -35.82 Million | -27.53 Million | -37.03 Million | -28.37 Million |
| Depreciation & Amortization | 58 Thousand | 338 Thousand | 519 Thousand | 395 Thousand | 303 Thousand | 175 Thousand |
| Deferred income taxes | -3.31 Million | 1.37 Million | - | 1000.00 | -68 Thousand | - |
| Stock-based compensation | 12.03 Million | 1.8 Million | 5.37 Million | 1.78 Million | 738 Thousand | 348 Thousand |
| Change in working capital | -267 Thousand | 1.82 Million | -1.63 Million | -4.55 Million | 4.92 Million | -379 Thousand |
| Other non-cash items | 110 Thousand | 2.47 Million | 58 Thousand | -2.15 Million | -72 Thousand | 18 Thousand |
| Investing Cash Flow | 8.88 Million | 26.95 Million | 10.75 Million | -42.56 Million | -20.62 Million | -1.46 Million |
| Investments in PPE | -78 Thousand | -2.25 Million | -488 Thousand | -1.02 Million | -605 Thousand | -1.46 Million |
| Acquisitions | - | 1.94 Million | - | - | - | - |
| Investment purchases | -6.11 Million | -35.56 Million | -94.57 Million | -61.63 Million | -22.51 Million | - |
| Sales/Maturities of investments | 15.08 Million | 64.34 Million | 105.8 Million | 20.1 Million | 2.5 Million | - |
| Other Investing Activities | - | -1.51 Million | - | - | - | - |
| Financing Cash Flow | 20.9 Million | -139 Thousand | 695 Thousand | 92.17 Million | 54.87 Million | 42.01 Million |
| Debt repayment | - | -8.45 Million | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | -45 Thousand | - |
| Common Stock Issuance | 25.44 Million | 18 Thousand | 695 Thousand | 96.25 Million | 54.91 Million | 42.01 Million |
| Other Financing Activities | -4.54 Million | -139 Thousand | 695 Thousand | -4.08 Million | 54.87 Million | 42.01 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -1.42 Million | 1.3 Million | -2.05 Million | -1.46 Million | 1.4 Million | 1.37 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 1.16 Million | 523 Thousand | 421 Thousand | -3.09 Million | 3.51 Million | -1.74 Million |
| Cash at beginning of period | 1.47 Million | 13.36 Million | 33.41 Million | 15.87 Million | 12.83 Million | 492 Thousand |
| Cash at end of period | 5.53 Million | 17.3 Million | 13.36 Million | 33.41 Million | 15.87 Million | 12.83 Million |
| Capital Expenditure | -78 Thousand | -2.25 Million | -488 Thousand | -1.02 Million | -605 Thousand | -1.46 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 4.05 Million | 3.94 Million | -20.05 Million | 17.54 Million | 3.03 Million | 12.34 Million |
| Free Cash Flow | -25.8 Million | -25.13 Million | -31.98 Million | -33.08 Million | -31.82 Million | -29.67 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -3.95 Million | 130 Thousand | -34.35 Million | -4.14 Million | -4.61 Million | -6.3 Million |
| Depreciation & Amortization | 15 Thousand | 15 Thousand | 58 Thousand | 19 Thousand | 12 Thousand | 14 Thousand |
| Deferred income taxes | - | - | -3.31 Million | - | - | - |
| Stock-based compensation | 486 Thousand | 414 Thousand | 12.03 Million | -32 Thousand | 482 Thousand | 463 Thousand |
| Change in working capital | -820 Thousand | -297 Thousand | -267 Thousand | 631 Thousand | -440 Thousand | -6.31 Million |
| Other non-cash items | -2.6 Million | -4.66 Million | 110 Thousand | -84 Thousand | -6000.00 | -53 Thousand |
| Investing Cash Flow | 5.1 Million | -13.1 Million | 8.88 Million | -2.67 Million | -2.94 Million | 9.75 Million |
| Investments in PPE | - | - | -78 Thousand | - | - | -78 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | -17.85 Million | -6.11 Million | -3.17 Million | -2.94 Million | - |
| Sales/Maturities of investments | 5.1 Million | 4.75 Million | 15.08 Million | 500 Thousand | - | 9.83 Million |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | -7000.00 | 19.04 Million | 20.9 Million | 175 Thousand | 72 Thousand | -2.86 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | -7000.00 | 19.04 Million | 25.44 Million | 174 Thousand | 72 Thousand | 3000.00 |
| Other Financing Activities | 4000.00 | - | -4.54 Million | 1000.00 | - | -2.86 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 597 Thousand | 129 Thousand | -1.42 Million | 47 Thousand | -1.45 Million | 1.02 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -1.41 Million | -426 Thousand | 1.16 Million | 584 Thousand | 1.01 Million | -7.33 Million |
| Cash at beginning of period | 6.75 Million | 5.53 Million | 1.47 Million | 11.64 Million | 19.08 Million | 24.38 Million |
| Cash at end of period | 5.05 Million | 6.75 Million | 5.53 Million | 5.53 Million | 11.64 Million | 19.08 Million |
| Capital Expenditure | - | - | -78 Thousand | - | - | -78 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -1.69 Million | 1.22 Million | 4.05 Million | -6.11 Million | -7.44 Million | -5.3 Million |
| Free Cash Flow | -6.79 Million | -4.71 Million | -25.8 Million | -3.61 Million | -4.57 Million | -12.27 Million |
LTOUF
FHELF
601975
6816
2517
VSEEW